Goldman Sachs
FBT icon

Goldman Sachs’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Goldman Sachs’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$472K Buy
2,348
+739
+46% +$153K ﹤0.01% 5640
2025
Q4 		$332K Sell
1,609
-2,132
-57% -$426K ﹤0.01% 5812
2025
Q3 		$671K Sell
3,741
-51,311
-93% -$8.74M ﹤0.01% 5324
2025
Q2 		$8.88M Buy
55,052
+14,897
+37% +$2.37M ﹤0.01% 2863
2025
Q1 		$6.83M Sell
40,155
-3,463
-8% -$601K ﹤0.01% 3041
2024
Q4 		$7.25M Buy
43,618
+15,095
+53% +$2.58M ﹤0.01% 3081
2024
Q3 		$4.9M Buy
28,523
+8,334
+41% +$1.38M ﹤0.01% 3362
2024
Q2 		$3.11M Buy
20,189
+13,326
+194% +$2M ﹤0.01% 3587
2024
Q1 		$1.06M Buy
6,863
+5,423
+377% +$827K ﹤0.01% 4319
2023
Q4 		$228K Sell
1,440
-14
-1% -$2.01K ﹤0.01% 5105
2023
Q3 		$213K Buy
+1,454
New +$222K ﹤0.01% 5026
2023
Q1 		– Sell
-1,536
Closed -$237K – 6014
2022
Q4 		$237K Sell
1,536
-1,030
-40% -$152K ﹤0.01% 5239
2022
Q3 		$339K Buy
+2,566
New +$360K ﹤0.01% 5234
2019
Q4 		– Sell
-10,852
Closed -$1.34M – 5265
2019
Q3 		$1.34M Sell
10,852
-28,924
-73% -$3.85M ﹤0.01% 3820
2019
Q2 		$5.6M Buy
+39,776
New +$5.49M ﹤0.01% 2766
2018
Q4 		– Sell
-2,612
Closed -$414K – 5364
2018
Q3 		$414K Buy
+2,612
New +$395K ﹤0.01% 4519
2018
Q2 		– Sell
-25,810
Closed -$3.43M – 5766
2018
Q1 		$3.43M Sell
25,810
-24,500
-49% -$3.34M ﹤0.01% 3194
2017
Q4 		$6.27M Sell
50,310
-4,731
-9% -$585K ﹤0.01% 2813
2017
Q3 		$6.82M Sell
55,041
-89
-0.2% -$10.5K ﹤0.01% 2884
2017
Q2 		$6.29M Sell
55,130
-211
-0.4% -$22.7K ﹤0.01% 2872
2017
Q1 		$5.83M Buy
55,341
+5,303
+11% +$531K ﹤0.01% 2815
2016
Q4 		$4.55M Buy
50,038
+38
+0.1% +$3.56K ﹤0.01% 3136
2016
Q3 		$4.99M Sell
50,000
-1,535
-3% -$151K ﹤0.01% 3049
2016
Q2 		$4.61M Sell
51,535
-1,156
-2% -$106K ﹤0.01% 2943
2016
Q1 		$4.61M Sell
52,691
-148,307
-74% -$13.1M ﹤0.01% 2781
2015
Q4 		$22.7M Sell
200,998
-4,919
-2% -$530K 0.01% 1675
2015
Q3 		$20.9M Sell
205,917
-94,083
-31% -$11.2M 0.01% 1683
2015
Q2 		$37.2M Sell
300,000
-150,226
-33% -$18.1M 0.01% 1337
2015
Q1 		$53.2M Buy
450,226
+150,226
+50% +$17M 0.02% 1047
2014
Q4 		$30.6M Sell
300,000
-230
-0.1% -$22.5K 0.01% 1506
2014
Q3 		$27.6M Sell
300,230
-9,912
-3% -$860K 0.01% 1559
2014
Q2 		$25.5M Sell
310,142
-456,941
-60% -$34.9M 0.01% 1607
2014
Q1 		$58.8M Buy
767,083
+22,877
+3% +$1.78M 0.02% 931
2013
Q4 		$51.5M Buy
744,206
+172,186
+30% +$11.3M 0.02% 1017
2013
Q3 		$37.1M Buy
572,020
+378,520
+196% +$23.9M 0.01% 1166
2013
Q2 		$11.3M Buy
+193,500
New +$11.1M ﹤0.01% 1988

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Goldman Sachs's FBT Position: Q1 2026 in Review

Goldman Sachs increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 46% in Q1 2026, buying an estimated $153K and bringing the position to 2,348 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #5640.

Goldman Sachs first reported a position in FBT in Q2 2013 and has held it in 36 quarters since. The position peaked at $58.8M in Q1 2014. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Goldman Sachs held 2,348 shares of First Trust NYSE Arca Biotechnology Index Fund worth $472K as of Q1 2026.
  • Goldman Sachs bought 739 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $153K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5640 holding.
  • Goldman Sachs first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 36 quarters since.
  • Goldman Sachs's First Trust NYSE Arca Biotechnology Index Fund position peaked at $58.8M in Q1 2014.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.